Article Details

GSK Receives $370 Million Settlement Payment in mRNA Patent Dispute with CureVac ...

Retrieved on: 2025-08-09 00:09:22

Tags for this article:

Click the tags to see associated articles and topics

GSK Receives $370 Million Settlement Payment in mRNA Patent Dispute with CureVac .... View article details on hiswai:

Excerpt

GSK has secured a $370 million upfront payment as part of a settlement agreement with CureVac, Pfizer, and BioNTech over mRNA patent disputes.

Article found on: www.geneonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo